Industry commentators have welcomed Chancellor Philip Hammond's plans to support the growth of early-stage UK companies, as announced in last week's Budget, but some are sceptical about whether the changes could help raise significantly more capital through tax-efficient vehicles such as EIS and VCTs.
The Chancellor launched the Patient Capital Review late last year in an attempt to overcome the barriers faced by young companies in the UK hoping to grow further. Chaired by Sir Damon Buffini, the taskforce recommended a three-pronged approach to tackling the issue, following a consultation with the industry. In his first Autumn Budget, Hammond has responded by announcing the government's intention to unlock over £20bn of new investment in UK knowledge-intensive scale-up businesses. Jack Rose: The Patient Capital Review reviewed He hopes to achieve this through the launch of a...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
